Updated:
Nanaline H. Duke Fund
The Nanaline H. Duke Fund was established in 1962 through the will of Nanaline H. Duke, widow of American Tobacco Company and Duke Energy founder James...
Nanaline H. Duke Fund
The Nanaline H. Duke Fund was established in 1962 through the will of Nanaline H. Duke, widow of American Tobacco Company and Duke Energy founder James Buchanan Duke. Unlike the broader Duke Endowment, this fund is single-purpose: it supports Duke University Hospital, the School of Medicine, and early-career medical research at Duke. The wealth originates from the Duke family's twin monopolies in cigarettes and hydroelectric power across the Carolinas, making this one of the longest-continuously-operating philanthropic medical endowments in the American South. Asset allocation is managed through DUMAC, Duke University's investment company, which blends the fund with the university's broader endowment pool. DUMAC's portfolio extends well beyond traditional equities and fixed income into alternatives including a documented cryptocurrency position in Filecoin, Bitcoin exposure, commodity allocations, and an Independent Return Portfolio based in Durham. The fund does not make direct grants to external entities—disbursements flow exclusively to Duke-affiliated medical programs, with a specific emphasis on the Strong Start Award program for early-career physician-scientists. Governance sits with The Duke Endowment's Board of Trustees, currently chaired by Charles C. Lucas III. Investment oversight is shared; Apollo Global Management's James Zelter sits on the DUMAC board, linking the fund to one of the largest alternative asset managers globally. DUMAC's investment team participates in forums like the Academy of Institutional Investors and benchmarks through NACUBO, following standard endowment-practice norms rather than operating as an independent family office. The fund also carries legacy real assets, including the Nanaline H. Duke Research Building on Duke's campus in Durham. The fund's structural differentiator is its complete absence of a return-maximization mandate. It is not a family office seeking to preserve multi-generational wealth nor an endowment growing to support a university broadly—it is a dedicated flow-through vehicle for medical philanthropy. Every dollar exists to fund Duke Medicine, and the trust's EIN and reporting sit within The Duke Endowment's administrative shell, not as a standalone operating entity. This architecture makes it a pure-play philanthropic instrument rather than an investment organization.
General information
Firm type
Foundation
Year founded
1962
Location
Region
North America
Country
United States
City
Charlotte
Corporate office
Charlotte, NC, United States
Principals
Charles C. Lucas III
Chair, The Duke Endowment Board of Trustees
James Zelter
DUMAC Board Member, Apollo Global Management Executive
Sector focus
Frequently asked questions
Who runs investment decisions for the Nanaline H. Duke Fund?
The fund's assets are managed by DUMAC, Duke University's dedicated investment management company, which oversees the combined university endowment pool. Day-to-day allocation decisions are made by DUMAC's investment team, with board-level oversight that includes Apollo Global Management executive James Zelter. The Duke Endowment Board of Trustees, chaired by Charles C. Lucas III, retains ultimate fiduciary responsibility.
How does the Nanaline H. Duke Fund differ from The Duke Endowment?
The Duke Endowment is a broad philanthropic foundation established by James Buchanan Duke in 1924, supporting higher education, healthcare, child welfare, and rural churches across the Carolinas. The Nanaline H. Duke Fund, created decades later in 1962 by Duke's widow, is a targeted sub-fund restricted to Duke University Hospital, the School of Medicine, and medical research—a significantly narrower mandate within the larger Endowment's administrative structure.
Does the Nanaline H. Duke Fund make direct investments or fund commitments?
The fund does not operate as a direct investor. Its capital is pooled with Duke University's endowment, managed by DUMAC, which allocates across asset classes including public equities, fixed income, real assets, commodities, and alternative investments with documented cryptocurrency exposure. All disbursements are grants to Duke-affiliated medical programs, not external investments.
What is the Strong Start Award program?
The Strong Start Award is a signature initiative of the Nanaline H. Duke Fund, designed to provide early-stage research funding for physician-scientists at the beginning of their academic careers at Duke's School of Medicine. The program targets the gap between fellowship completion and independent research grant eligibility, a critical period when many promising researchers leave academic medicine for lack of funding.
Where does the underlying wealth come from?
The wealth originates from James Buchanan Duke's industrial empire—the American Tobacco Company, which controlled approximately 90% of U.S. cigarette production by the early 1900s, and Duke Energy (originally Duke Power), which harnessed hydroelectric power across the Carolina Piedmont. Nanaline H. Duke, his widow, directed her share of the fortune into this medical fund upon her death in 1962.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: